Judeth Melgar Puyat, in W Hollywood, CA - Pharmacist

Judeth Melgar Puyat, is a Pharmacist based in W Hollywood, California. Judeth Melgar Puyat is licensed to practice in California (license number RPH55485) and her current practice location is 8000 W Sunset Blvd, W Hollywood, California. She can be reached at her office (for appointments etc.) via phone at (323) 656-1477.

NPI number for Judeth Melgar Puyat is 1710416557 and her current mailing address is 435 S Curson Ave Apt 6j, Los Angeles, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1710416557.

Contact Information

	Judeth Melgar Puyat,
	8000 W Sunset Blvd, W Hollywood, CA 90046-2439
	(323) 656-1477
	(323) 282-3344

Healthcare Provider's Profile

Full Name	Judeth Melgar Puyat
Gender	Female
Speciality	Pharmacist
Location	8000 W Sunset Blvd, W Hollywood, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1710416557
Provider Enumeration Date: 06/06/2017
Last Update Date: 06/06/2017

Medical Identifiers

Medical identifiers for Judeth Melgar Puyat such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1710416557	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	RPH55485 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Judeth Melgar Puyat is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Judeth Melgar Puyat, 435 S Curson Ave Apt 6j, Los Angeles, CA 90036-5246 Ph: () -	Judeth Melgar Puyat, 8000 W Sunset Blvd, W Hollywood, CA 90046-2439 Ph: (323) 656-1477

News Archive

BiondVax Pharmaceuticals declares closing of over-allotment option granted to underwriters

BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases, today announced the closing of an additional and partial exercise of the over-allotment option granted to the underwriters.

Viewpoints: Policies being canceled were once considered substandard; that insurance 'was working for people'

The weirdest thing about the ongoing conniption about the cancellation of people's health insurance plans - supposedly as a result of Obamacare - is the notion that these are plans people liked, even loved. When did that happen? It wasn't so long ago - months, even weeks - when the health insurance companies were being roundly cursed for their ruthless mistreatment of individual health plan customers. Constant rate hikes. Cancellations after policyholders got sick. Endless hoops to jump through to file a claim or appeal a rejection (Michael Hiltzik, 10/31).

Proton pump inhibitor use associated with fracture risk in postmenopausal women

Proton pump inhibitors, medications that suppress acid in the stomach, appear to be associated with fractures in postmenopausal women and bacterial infections in many patients, and higher doses do not appear any more beneficial for treating bleeding ulcers, according to a series of reports in the May 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Global initiative to eradicate polio could provide benefits of at least US$40-50 billion

A new study released today estimates that the global initiative to eradicate polio could provide net benefits of at least US$40-50 billion if transmission of wild polioviruses is interrupted within the next five years. The study provides the first rigorous evaluation of the benefits and costs of the Global Polio Eradication Initiative (GPEI)-the single largest project ever undertaken by the global health community. The study comes at a crucial time-following an outbreak in the Republic of the Congo and one in Tajikistan earlier this year-that highlight the risk of delays in finishing the job on polio.

Study examines various state laws that address adolescent sexual behavior

While statutory rape laws have been enacted to protect minors from sexual abuse by adults or peers, more teenagers are engaging in sexual activity before the legal age of consent and are facing sexual assault charges.

Judeth Melgar Puyat, - Pharmacist in W Hollywood, CA